8:30 am – 10:05 am |
Session XI |
Animal models and viral pathogenesis |
| |
Kenneth Williams
(Plenary Speaker) |
Studies of monocyte/macrophages in a monkey model of NeuroAIDS define mechanisms of disease progression and potential therapies |
| |
Thomas E. Lane (Plenary Speaker)
|
A protective role for the CXC chemokine receptor 2 (CXCR2) in host defense following viral infection of the central nervous system |
| |
Yuri Persidsky |
Utility of SCID mouse model for HIV-1 encephalitis for studies of neuropathogenesis, blood brain barrier injury, and development of new treatment approaches |
| |
Woong-Ki Kim |
Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage |
| |
Robyn S. Klein |
Hold me back: CXCL12 and CD8 T cell trafficking during West Nile virus encephalitis |
10:05 am – 10:45 am |
Coffee Break |
|
10:45 am – 12:25 pm |
Session XII |
Late-breaking events in neurovirology and immunology: recent cutting-edge findings
|
| |
Juan Carlos de la Torre
(Plenary Speaker) |
Neuroimmunologic mediated disorders induced by non-cytolytic ribovirus persistent infection |
| |
Lisa Boulanger |
MHC class I proteins in development and plasticity of the normal, uninfected brain |
| |
Dorian McGavern |
Window on the diseased brain |
| |
Bruno Conti |
Sickness syndrome: Recent advances on interleukin 18 |
| |
Dongxian Zhang |
Early activation of an interferon signaling pathway in a mouse model of amyotrophic lateral sclerosis |
12:25 pm - 12:30 pm |
Concluding Remarks and Adjournment
Peter G. E. Kennedy
|
|
| 12:30 pm - ??? |
Afternoon in San Diego and start of the Annual Meeting of the Society for Neuroscience |
|